Jens Verheyen

2.5k total citations
66 papers, 1.3k citations indexed

About

Jens Verheyen is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Jens Verheyen has authored 66 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Infectious Diseases, 28 papers in Virology and 27 papers in Epidemiology. Recurrent topics in Jens Verheyen's work include HIV Research and Treatment (28 papers), HIV/AIDS drug development and treatment (26 papers) and Hepatitis C virus research (20 papers). Jens Verheyen is often cited by papers focused on HIV Research and Treatment (28 papers), HIV/AIDS drug development and treatment (26 papers) and Hepatitis C virus research (20 papers). Jens Verheyen collaborates with scholars based in Germany, United States and Belgium. Jens Verheyen's co-authors include Rolf Kaiser, Monique Nijhuis, Annemarie M. J. Wensing, Herbert Pfister, Axel Fun, Guido Gerken, Ali Canbay, Daniel Hoffmann, Paul Manka and Kristof Theys and has published in prestigious journals such as PLoS ONE, Applied and Environmental Microbiology and Hepatology.

In The Last Decade

Jens Verheyen

63 papers receiving 1.3k citations

Peers

Jens Verheyen

EPIDE

HEPAT

VIROL

James J. Kohler United States

Anders Sönnerborg Sweden

Ashwin Balagopal United States

Juraj Petrík United Kingdom

Ran Yan China

Nancy S. Shulman United States

Susan Sloan United States

William E. Hornbuckle United States

Christophe Ramière France

Yumei Wen China

James J. Kohler United States

Jens Verheyen

559 ×0.9

262 ×0.5

EPIDE

137 ×0.3

HEPAT

355 ×0.8

VIROL

283 ×1.3

Citations per year, relative to Jens Verheyen Jens Verheyen (= 1×) peers James J. Kohler

Countries citing papers authored by Jens Verheyen

Since Specialization

Citations

This map shows the geographic impact of Jens Verheyen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Verheyen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Verheyen more than expected).

Fields of papers citing papers by Jens Verheyen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Verheyen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Verheyen. The network helps show where Jens Verheyen may publish in the future.

Co-authorship network of co-authors of Jens Verheyen

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Verheyen. A scholar is included among the top collaborators of Jens Verheyen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Verheyen. Jens Verheyen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Korth, Johannes, Olympia E. Anastasiou, Jan Hinrich Bräsen, et al.. (2019). The detection of BKPyV genotypes II and IV after renal transplantation as a simple tool for risk assessment for PyVAN and transplant outcome already at early stages of BKPyV reactivation. Journal of Clinical Virology. 113. 14–19. 8 indexed citations

Korth, Johannes, Olympia E. Anastasiou, Jens Verheyen, et al.. (2018). Impact of immune suppressive agents on the BK-Polyomavirus non coding control region. Antiviral Research. 159. 68–76. 10 indexed citations

Anastasiou, Olympia E., Marek Widera, Sandra Westhaus, et al.. (2018). Clinical Outcome and Viral Genome Variability of Hepatitis B Virus–Induced Acute Liver Failure. Hepatology. 69(3). 993–1003. 20 indexed citations

Widera, Marek, Martin Däumer, Hauke Walter, et al.. (2017). HIV-1 persistent viremia is frequently followed by episodes of low-level viremia. Medical Microbiology and Immunology. 206(3). 203–215. 13 indexed citations

Hoffmann, Daniel, Jürg Böni, Sabine Yerly, et al.. (2016). Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors?. Journal of Antimicrobial Chemotherapy. 72(3). dkw493–dkw493. 12 indexed citations

Joedicke, Jara J., et al.. (2016). Reduced Frequencies and Activation of Regulatory T Cells After the Treatment of HIV-1-Infected Individuals with the CCR5 Antagonist Maraviroc Are Associated with a Reduction in Viral Loads Rather Than a Direct Effect of the Drug on Regulatory T Cells. Viral Immunology. 29(3). 192–196. 1 indexed citations

Manka, Paul, Jens Verheyen, Guido Gerken, & Ali Canbay. (2016). Liver Failure due to Acute Viral Hepatitis (A-E). Visceral Medicine. 32(2). 80–85. 60 indexed citations

Manka, Paul, Lars P. Bechmann, Jason D. Coombes, et al.. (2015). Hepatitis E Virus Infection as a Possible Cause of Acute Liver Failure in Europe. Clinical Gastroenterology and Hepatology. 13(10). 1836–1842.e2. 72 indexed citations

Neumann‐Fraune, Maria, et al.. (2013). Inferring Short-Range Linkage Information from Sequencing Chromatograms. PLoS ONE. 8(12). e81687–e81687. 11 indexed citations

10.

Verheyen, Jens, et al.. (2012). Extraction of viral nucleic acids: Comparison of five automated nucleic acid extraction platforms. Journal of Clinical Virology. 54(3). 255–259. 50 indexed citations

11.

Fun, Axel, Annemarie M. J. Wensing, Jens Verheyen, & Monique Nijhuis. (2012). Human Immunodeficiency Virus gag and protease: partners in resistance. Retrovirology. 9(1). 63–63. 106 indexed citations

12.

Vehreschild, Jörg Janne, Paul J. Bröckelmann, Christopher Bangard, et al.. (2011). Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients. Epidemiology and Infection. 140(10). 1848–1852. 23 indexed citations

13.

Heider, Dominik, Jens Verheyen, & Daniel Hoffmann. (2011). Machine learning on normalized protein sequences. BMC Research Notes. 4(1). 94–94. 12 indexed citations

14.

Anadol, Evrim, Rolf Kaiser, Jens Verheyen, et al.. (2010). Transmission of Human Immunodeficiency Virus I Drug Resistance - a Case Report. What are the Clinical Implications?. European journal of medical research. 15(5). 225–225. 1 indexed citations

15.

Knops, Elena, Martin Däumer, Vladimir Kartashev, et al.. (2010). Evolution of protease inhibitor resistance in the gag and pol genes of HIV subtype G isolates. Journal of Antimicrobial Chemotherapy. 65(7). 1472–1476. 8 indexed citations

16.

Verheyen, Jens, Chris Verhofstede, Elena Knops, et al.. (2009). High prevalence of bevirimat resistance mutations in non-B subtypes and in PI-resistant HIV isolates. Antiviral Therapy. 14(4). 127. 1 indexed citations

17.

Verheyen, Jens, Elena Knops, Bernd Kupfer, et al.. (2008). Prevalence of C-terminal gag cleavage site mutations in HIV from therapy-naïve patients. Journal of Infection. 58(1). 61–67. 20 indexed citations

18.

Nijhuis, Monique, Noortje M. van Maarseveen, Jens Verheyen, & Charles A. Boucher. (2008). Novel mechanisms of HIV protease inhibitor resistance. Current Opinion in HIV and AIDS. 3(6). 627–632. 7 indexed citations

19.

Bönig, Halvard, Annette Wundes, Jens Verheyen, et al.. (2000). In vivo cytokine responses to interleukin-2 immunotherapy after autologous stem cell transplantation in children with solid tumors. Bone Marrow Transplantation. 26(1). 91–96. 10 indexed citations

20.

Körholz, Dieter, et al.. (1998). Evaluation of follow-up investigations in osteosarcoma patients: Suggestions for an effective follow-up program. Medical and Pediatric Oncology. 30(1). 52–58. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact